By 2035, will the FDA approve a drug that slows the yearly progression of Alzheimer's disease by at least 50%?
$407 volume
By 2035, will the FDA approve a drug that slows the yearly progression of Alzheimer's disease by at least 50%?
57.1%$0.57
Loading chart...
Selected BetBy 2035, will the FDA approve a drug that slows the yearly progression of Alzheimer's disease by at least 50%?
M
Trading via ManifoldMarket Volume$407
Yes
No